Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
4
×
life sciences
medicare
national blog main
wisconsin blog main
wisconsin top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
aduro biotech
alzheimer's disease
biogen
cancer immunotherapy
deals
drug prices
eli lilly
johnson & johnson
medicaid
novartis
startups
What
price
4
×
bio
companies
drug
plan
roundup
year
adversity
alzheimer’s
answer
approval
away
beats
biogen’s
biopharmaceutical
cold
convo
dealing
democratic
dems
different
discontent
discussed
drugs
earlier
early
election
exact
fail
failures
flu
forecasts
gene
high
historically
house
increases
industry
latest
leaders
Language
unset
Current search:
price
×
cancer
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
6 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up
